Clinical trial
Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
NCT00344981 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00344981 |
|---|---|
| Title | Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression |
| Official title | A Study to Probe The Safety And Durability of Tenofovir And a Cell Cycle Agent to Maintain Viral Suppression |
| Acronym | HADIT |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, AIDS |
| Intervention type | Drug |
| Interventions | Tenofovir, Hydroxyurea |
| Enrollment | 9 |
| Start date | Jun 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jun 27, 2006 |
| Last update posted | May 11, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: